Chapter 12: Q2ISTQ (page 610)
Research and development costs are:
(a) expensed under GAAP.
(b) expensed under IFRS.
(c) expensed under both GAAP and IFRS.
(d) None of the above.
Short Answer
Expensed under GAAP
Chapter 12: Q2ISTQ (page 610)
Research and development costs are:
(a) expensed under GAAP.
(b) expensed under IFRS.
(c) expensed under both GAAP and IFRS.
(d) None of the above.
Expensed under GAAP
All the tools & learning materials you need for study success - in one app.
Get started for free(Accounting for R&D Costs) In 2015, Wright Tool Company purchased a building site for its proposed research and development laboratory at a cost of \(60,000. Construction of the building was started in 2015. The building was completed on December 31, 2016, at a cost of \)320,000 and was placed in service on January 2, 2017. The estimated useful life of the building for depreciation purposes was 20 years. The straight-line method of depreciation was to be employed, and there was no estimated residual value.
Management estimates that about 50% of the projects of the research and development group will result in long-term benefits (i.e., at least 10 years) to the corporation. The remaining projects either benefit the current period or are abandoned before completion. A summary of the number of projects and the direct costs incurred in conjunction with the research and development activities for 2017 appears below.
Number of Projects | Salaries and Employee Benefits | Other Expenses (excluding Building Depreciation Charges) | |
Completed projects with long-term benefits | 15 | \( 90,000 | \)50,000 |
Abandoned projects or projects that benefit the current period | 10 | 65,000 | 15,000 |
Projects in process—results indeterminate | 5 | 40,000 | 12,000 |
Total | 30 | \(195,000 | \)77,000 |
Upon recommendation of the research and development group, Wright Tool Company acquired a patent for manufacturing rights at a cost of $88,000. The patent was acquired on April 1, 2016, and has an economic life of 10 years.
Instructions
If generally accepted accounting principles were followed, how would the items above relating to research and development activities be reported on the following financial statements?
(a) The company’s income statement for 2017.
(b) The company’s balance sheet as of December 31, 2017.
Be sure to give account titles and amounts, and briefly justify your presentation.
Simon Company determines that its goodwill is impaired. It finds that its implied goodwill is \(360,000 and its recorded goodwill is \)400,000. The fair value of its identifiable assets is $1,450,000. What is the amount of goodwill impaired?
Question: Where can authoritative IFRS guidance related to intangible assets be found?
Use the information in IFRS12-6. Assume that at the end of the year following the impairment (after recording amortization expense), the estimated recoverable amount for the patent is \(130,000. Prepare Kenoly’s journal entry, if needed.
Kenoly Corporation owns a patent that has a carrying amount of \)300,000. Kenoly expects future net cash flows from this patent to total \(210,000 over its remaining life of 10 years. The recoverable amount of the patent is \)110,000. Prepare Kenoly’s journal entry, if necessary, to record the loss on impairment.
What are the main distinctions between a traditional financial instrument and a derivative financial instrument?
What do you think about this solution?
We value your feedback to improve our textbook solutions.